← FDA Drug Approvals (Drugs@FDA)

PIPERAZINE CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LANNETT · Approved 1974-07-25

Drug application

FDA Application #

ANDA080963

Application type

Abbreviated New Drug Application (Generic)

Brand name

PIPERAZINE CITRATE

Generic name

Piperazine Citrate

Active ingredients

PIPERAZINE CITRATE

Dosage form

SYRUP

Route

ORAL

Marketing status

Discontinued

Sponsor

LANNETT

First approval

1974-07-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown